As research continues to evolve, therapies targeting multiple metabolic pathways may continue shaping the future of metabolic health and long-term weight management
As the dose increases, results typically improve
It is not approved for any human use
The absolute incidence of pancreatitis in clinical trials has been consistently low across studies, typically affecting fewer than 1 in 200 patients over multi-year follow-up periods
Good customer interaction too
Across preclinical studies, Epitalon has shown: Telomerase activation and telomere extension: Via TRAP assays and fibroblast lifespan extension beyond the Hayflick limit Epigenetic remodeling: Reversal of chromatin aging, histone modulation, and gene promoter binding Redox homeostasis: Increased antioxidant enzymes (SOD, NQO1, catalase) and reduced ROS, lipid peroxidation, and DNA damage Circadian restoration: Upregulation of AANAT/pCREB, normalized melatonin and cortisol rhythms, and clock gene modulation in humans Cancer risk reduction: Reduced tumor multiplicity and delayed onset in HER-2/neu and colon cancer models